Sorangicin A Is Active against <i>Chlamydia</i> in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment

Current treatment of <i>Chlamydia trachomatis</i> using doxycycline and azithromycin introduces detrimental side effects on the host’s microbiota. As a potential alternative treatment, the myxobacterial natural product sorangicin A (SorA) blocks the bacterial RNA polymerase. In this study we analyze...

Descripción completa

Detalles Bibliográficos

Autores principales:	Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding, Lars C. Hanker, Marc Stadler, Mark Brönstrup, Rolf Müller, Kensuke Shima, Jan Rupp
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-04-01
Colección:	Antibiotics
Materias:	sorangicin A antibiotics <i>Chlamydia trachomatis</i> <i>Chlamydia muridarum</i> mouse novel therapeutics
Acceso en línea:	https://www.mdpi.com/2079-6382/12/5/795
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!